Quotient Biodiagnostics Signs 36-month Agreement with the Premier Health Alliance to Supply Blood Bank Reagents to its 2,600 Member Hospitals

NEWTOWN, PA (August 15, 2012)  Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has entered into a 36 month supply agreement with Premier healthcare alliance.  The agreement is effective November 1st, 2012 and includes Quotient’s complete range of blood bank reagents, including its recently launched ALBAcyte® line of reagent red blood cell products, at specially negotiated pricing and terms.

Get Answers Here